Based on data from the past 90 days ending February 19, 2026, Tarsus Pharmaceuticals's three largest insider shareholders are TenPercentOwner Capital Ix, Llc Vivo (2.47Mn shares), TenPercentOwner Investments, Lp Rtw (2.01Mn shares), Director Michael Ackermann (1.31Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Capital Ix, Llc Vivo | 2,469,001 | 05 May, 2022 | |
| Investments, Lp Rtw | 2,013,601 | 07 May, 2021 | |
| Michael Ackermann | 1,308,273 | 17 Jun, 2022 | |
| Bobak R. Azamian | President/Ceo And Board Chair | 859,741 | 08 Dec, 2025 |
| William J Phd Link | 128,832 | 17 Dec, 2025 | |
| Seshadri Neervannan | Chief Operating Officer | 79,658 | 18 Dec, 2025 |
| Bryan Wahl | General Counsel | 51,712 | 20 Mar, 2025 |
| Aziz Mottiwala | Chief Commercial Officer | 47,557 | 11 Jun, 2025 |
| Elizabeth Yeu Lin | Chief Medical Officer | 37,807 | 17 Dec, 2025 |
| Jeffrey S Farrow | Nan | 36,704 | 18 Jun, 2025 |
| Leonard M. Greenstein | Chief Financial Officer | 26,785 | 21 Apr, 2023 |
| Dianne C. Whitfield | Chief Human Resources Officer | 23,393 | 06 Jan, 2026 |
| Andrew D. Goldberg | 16,700 | 16 Jun, 2025 | |
| Wendy L Yarno | 13,700 | 16 Jun, 2025 | |
| Bhaskar Chaudhuri | 8,700 | 16 Jun, 2025 | |
| Rosemary A Crane | 5,350 | 25 Jun, 2024 | |
| Scott W Morrison | 4,684 | 16 Sep, 2025 | |
| Mark J. Holdbrook | V.P. And Clinical Affairs | 3,191 | 21 Mar, 2023 |
| Jose M. Trevejo | Chief Medical Officer | 2,251 | 22 Dec, 2023 |
| Katherine Goodrich | 2,233 | 14 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Jan, 2026 | Dianne C. Whitfield | Common Stock | D | 5,715 | $80.09 | 33,243 | D | S |
| 02 Jan, 2026 | Dianne C. Whitfield | Common Stock | D | 893 | $82.93 | 23,393 | D | S |
| 02 Jan, 2026 | Dianne C. Whitfield | Common Stock | D | 835 | $81.90 | 24,286 | D | S |
| 02 Jan, 2026 | Dianne C. Whitfield | Common Stock | D | 8,122 | $80.71 | 25,121 | D | S |
| 24 Dec, 2025 | Bobak R. Azamian | Common Stock | D | 5,443 | $82.41 | 858,548 | I | S |
| 24 Dec, 2025 | Bobak R. Azamian | Common Stock | D | 557 | $83.54 | 857,991 | I | S |
| 24 Dec, 2025 | Bobak R. Azamian | - | - | 857,991 | I | |||
| 24 Dec, 2025 | Bobak R. Azamian | - | - | 858,548 | I | |||
| 16 Dec, 2025 | Seshadri Neervannan | - | - | 475 | I | |||
| 16 Dec, 2025 | Seshadri Neervannan | Common Stock | D | 950 | $0.00 | 79,183 | D | G |
| 16 Dec, 2025 | Seshadri Neervannan | - | - | 79,183 | D | |||
| 16 Dec, 2025 | Seshadri Neervannan | Common Stock | A | 475 | $0.00 | 475 | I | G |
| 16 Dec, 2025 | Dianne C. Whitfield | Common Stock | D | 7,397 | $80.10 | 38,958 | D | S |
| 16 Dec, 2025 | Elizabeth Yeu Lin | Common Stock | D | 2,078 | $79.50 | 21,941 | D | S |
| 15 Dec, 2025 | William J Phd Link | Common Stock | D | 1,148 | $82.39 | 128,832 | D | S |
| 15 Dec, 2025 | William J Phd Link | - | - | 129,980 | D | |||
| 15 Dec, 2025 | William J Phd Link | - | - | 0 | I | |||
| 15 Dec, 2025 | William J Phd Link | - | - | 136,286 | D | |||
| 15 Dec, 2025 | William J Phd Link | - | - | 4,766 | I | |||
| 15 Dec, 2025 | William J Phd Link | Common Stock | D | 5,680 | $80.71 | 4,766 | I | S |